Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Observational Study Assessing Safety and Efficacy of Biosimilar of Tocilizumab in Giant Cell Arteritis (GCA) With Active Aortitis

NCT06271018 is registered in ClinicalTrials.gov with Groupe français d'étude des Maladies Inflammatoires de loeil as lead sponsor.

NCT NCT06271018
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06271018 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Observational Study Assessing Safety and Efficacy of Biosimilar of Tocilizumab in Giant Cell Arteritis (GCA) With Active Aortitis
Lead sponsor
Groupe français d'étude des Maladies Inflammatoires de loeil
Phase
Observational
Overall status
Recruiting
Start date
March 27, 2024
Completion date
March 27, 2028
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aortitis, giant cell arteritis (gca)